An Economic Model to Compare Linezolid, Vancomycin, and Teicoplanin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia In Brazil

May 1, 2015, 00:00
10.1016/j.jval.2015.03.1373
https://www.valueinhealthjournal.com/article/S1098-3015(15)01430-8/fulltext
Title : An Economic Model to Compare Linezolid, Vancomycin, and Teicoplanin for the Treatment of Confirmed Methicillin-Resistant Staphylococcus Aureus Nosocomial Pneumonia In Brazil
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01430-8&doi=10.1016/j.jval.2015.03.1373
First page : A236
Section Title : Infection
Open access? : No
Section Order : 839
Categories :
Tags :
Regions :
ViH Article Tags :